EichorEICHOR
Study identifier: NCT07694375 Synced from ClinicalTrials.gov · August 07, 2026
● Study status: Recruiting

A Study of CA201A Eye Drops to Prevent Corneal Endothelial Cell Loss in Patients Undergoing Cataract Surgery

Condition: Corneal Endothelial Cell Loss · Corneal Endothelial Damage Following the Hard Nuclear Cataract Surgery  ·  Sponsor: Caravel Oculus Pty Ltd

PhasePhase 2
Planned participants200
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

This study is designed to assess whether an investigational eye drop called CA201A can help protect the cornea (the outer covering of the eye) and reduce damage to corneal endothelial cells following cataract surgery, without causing significant side effects. Cataract surgery is one of the common surgical procedures, however, it can sometimes lead to a loss of corneal endothelial cells, which are essential for maintaining the corneal clarity and long-term eye health. About 200 adults in Australia who are scheduled to have cataract surgery will be enrolled in this study following eligibility check. All eligible participants will be randomly assigned (by chance) to receive either the CA201A eye drops or a similar eye drop without the active ingredient. Neither the participant nor the study doctor will know the treatment each participant is receiving until the study is completed. All enrolled participants will place 1 drop of CA201A four times daily, starting 7 days prior to the surgery, continue on the day of surgery, and then keep using them for 4 weeks following surgery. After treatment, participants will be followed for up to 12 weeks after surgery in order to monitor safety and assess how well the treatment works. All participants will undergo standard cataract surgery and receive usual care; the study eye drops will be given in addition to this routine treatment. Throughout the study, doctors will measure changes in corneal endothelial cell density and perform other eye…

This description comes directly from the study's public registry record.

Talk to the study team

Sandy Lai  ·  +886227119697  ·  sandylai@caraveloculus.com

Always discuss trial participation with your own doctor first.

Locations (8)

Canberra Eye SurgeonsDeakin, Australian Capital Territory, AustraliaNot Yet Recruiting
Nexus Eye Care NorwestBaulkham Hills, New South Wales, AustraliaNot Yet Recruiting
Nexus Eye Care BlacktownBlacktown, New South Wales, AustraliaNot Yet Recruiting
Eastwood Eye SpecialistsEastwood, New South Wales, AustraliaRecruiting
Sydney Retina Clinic & Day SurgerySydney, New South Wales, AustraliaRecruiting
Adelaide Eye and Retina CentreAdelaide, South Australia, AustraliaNot Yet Recruiting
Hobart Eye SurgeonsHobart, Tasmania, AustraliaNot Yet Recruiting
Launceston Eye DoctorsLaunceston, Tasmania, AustraliaNot Yet Recruiting

Sponsor or site team? See the site landscape for this trial — listed sites, countries, and recruiting-density context.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →